UNSPSC 51172416: Amylase/bile salts/dehydrocholic acid/lipase/pepsin/proteolytic

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA500. This VA Drug Class (GA500) classifies this compound as belonging to the group DIGESTANTS.

UNSPSC 51172416 Amylase/bile salts/dehydrocholic acid/lipase/pepsin/proteolytic (Commodity) represents diagnostic enzyme reagents and related biochemical products used in laboratory testing. The recent state and local activity under this code centers on drug testing and specimen analysis services—specifically immunoassay screening and confirmatory testing protocols that rely on enzymatic reagents and related analytical methodologies. State and local issuing bodies soliciting under this code span criminal justice departments, community supervision agencies, and other public health and law enforcement entities that contract for drug screening and testing capacity. The work encompasses staffing collection sites, operating laboratory information systems, performing multi-panel immunoassay screens with confirmatory testing (LC/MS/MS or GC/MS), and alternative methodologies including oral fluid and hair testing, all of which depend on the enzymatic and biochemical products this code describes.

Activity under the code appears concentrated in Texas, where Collin County Community Supervision and Corrections Department issued RFP 2026-327 for Offender Specimen Collection and Drug Testing Services with a response deadline of July 23, 2026 and an estimated contract value of $600,000. The scope encompasses approximately 25,031 annual tests across two collection sites in Plano and McKinney, with the successful vendor required to maintain lab certification from SAMHSA, TX DPS, or CAP and to price services on a per-test basis under three service models (screening only, confirmation after screening, and screening with automatic confirmation). The contract term begins September 1, 2026, with an anticipated award date of August 10, 2026, and includes three optional one-year renewal periods not to exceed five years total. Beyond this single identified opportunity, the source does not surface additional recent state and local activity under the code.